Breast cancer and hormone-replacement therapy: the Million Women Study

Lancet. 2003 Oct 18;362(9392):1329; author reply 1330-1. doi: 10.1016/s0140-6736(03)14592-8.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Breast Neoplasms / chemically induced
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / mortality
  • Cohort Studies
  • Drug Combinations
  • Estrogen Receptor Modulators / administration & dosage
  • Estrogen Receptor Modulators / adverse effects
  • Estrogens / administration & dosage
  • Estrogens / adverse effects
  • Female
  • Hormone Replacement Therapy / adverse effects*
  • Hormone Replacement Therapy / methods
  • Humans
  • Incidence
  • Norpregnenes / administration & dosage
  • Norpregnenes / adverse effects
  • Progestins / administration & dosage
  • Progestins / adverse effects
  • Risk Factors

Substances

  • Drug Combinations
  • Estrogen Receptor Modulators
  • Estrogens
  • Norpregnenes
  • Progestins
  • tibolone